Folate Therapy and In-Stent Restenosis after Coronary Stenting
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B6, and vitamin B12 (referred to as folate therapy) on the risk of angiographic restenosis after coronary-stent placement in a double-blind, multicenter trial. METHODS: A total of 636 patients who had undergone successful coronary stenting were randomly assigned to receive 1 mg of folic acid, 5 mg of vitamin B6, and 1 mg of vitamin B12 intravenously, followed by daily oral doses of 1.2 mg of folic acid, 48 mg of vitamin B6, and 60 microg of vitamin B12 for six months, or to receive placebo. The angiographic end points (minimal luminal diameter, late loss, and restenosis rate) were assessed at six months by means of quantitative coronary angiography. RESULTS: At follow-up, the mean (+/-SD) minimal luminal diameter was significantly smaller in the folate group than in the placebo group (1.59+/-0.62 mm vs. 1.74+/-0.64 mm, P=0.008), and the extent of late luminal loss was greater (0.90+/-0.55 mm vs. 0.76+/-0.58 mm, P=0.004). The restenosis rate was higher in the folate group than in the placebo group (34.5 percent vs. 26.5 percent, P=0.05), and a higher percentage of patients in the folate group required repeated target-vessel revascularization (15.8 percent vs. 10.6 percent, P=0.05). Folate therapy had adverse effects on the risk of restenosis in all subgroups except for women, patients with diabetes, and patients with markedly elevated homocysteine levels (15 micromol per liter or more) at baseline. CONCLUSIONS: Contrary to previous findings, the administration of folate, vitamin B6, and vitamin B12 after coronary stenting may increase the risk of in-stent restenosis and the need for target-vessel revascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Trials of homocysteine-reducing vitamin therapy have been disappointing, however.78 -82”
From Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee (2006) · cites this paper as [81]
Citations
Cites
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Patterns and Mechanisms of In-Stent Restenosis: A Serial Intravascular Ultrasound Study
Hoffmann, R., Mintz, G. S., Dussaillant, G. R., Popma, J. J., Pichard, A. D., Satler, L. F., Kent, K. M., Griffin, J., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1247 · Cited by 1,247
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. F., & Rosenberg, I. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401901 · Cited by 1,117
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J., & James, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002725200 · Cited by 640
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Self-citationIngrosso, D., Cimmino, A., Perna, A. F., Masella, L., De Santo, N. G., De Bonis, M. L., Vacca, M., D'Esposito, M., D'Urso, M., Galletti, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13372-7 · Cited by 427
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Research works printed but not linked: 3
- Cook J, 2002, J Vasc Surg, 35, 158
- 10.1097/00043798-200102000-00002 · doi:10.1097/00043798-200102000-00002
- Benoit C, 1999, Arch Mal Coeur Vaiss, 92, 1457
Cited by
Items 101–200 of 334
Eilat-Adar, S., & Goldbourt, U. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.011 · Cited by 53
Micronutrients and Older Adults
Marian, M. J., & Sacks, G. S. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609332177 · Cited by 64
Liu, Y., Tian, T., Zhang, H., Gao, L., & Zhou, X. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.032 · Cited by 50
Ahmad, A., Corban, M., Toya, T., Sara, J. D. S., Lerman, B., Park, J. Y., Lerman, L. O., & Lerman, A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017746 · Cited by 47
Murthy, S. N., Obregon, D. F., Chattergoon, N. N., Fonseca, N. A., Mondal, D., Dunne, J. B., Díez, J. G., Jeter, J. R., Kadowitz, P. J., Agrawal, K. C., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.12.008 · Cited by 47
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
Dierkes, J., Luley, C. H., & Westphal, S. (2007) · PubMed Central · Cited by 55
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1
Ali, Z. A., Pérez, V. D. J., Yuan, K., Orcholski, M. E., Pan, S., Qi, W., Chopra, G., Adams, C. M., Kojima, Y., Leeper, N. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77484 · Cited by 45
Novel Therapies Targeting Vascular Endothelium
Tousoulis, D., Antoniades, C. A., Κούμαλλος, Ν., Marinou, K., Stefanadi, E., Latsios, G., & Stefanadis, C. (2006) · Endothelium · doi:10.1080/10623320601061714 · Cited by 45
The Role of Nutraceuticals in Male Fertility
Ko, E., & Sabanegh, E. S. (2013) · Urologic Clinics of North America · doi:10.1016/j.ucl.2013.08.003 · Cited by 46
Cardiovascular effects of B-vitamins and/or N-3 fatty acids: The Su.Fol.Om3 trial
Blacher, J., Czernichow, S., Paillard, F., Ducimetière, P., Herçberg, S., & Galan, P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.060 · Cited by 42
Cohen, E., Margalit, I., Shochat, T., Goldberg, E., & Krause, I. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00618-x · Cited by 42
Witte, K. K., & Clark, A. L. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9194-4 · Cited by 42
The Role of Over‐the‐Counter Supplements for the Treatment of Male Infertility—Fact or Fiction?
Ko, E., & Sabanegh, E. S. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.013730 · Cited by 42
Zhang, C., Wang, Z., Qin, Y., Yu, F., & Zhou, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107060 · Cited by 48
NHG-Standaard Cardiovasculair risicomanagement
Wiersma, T., Boukes, F., Geijer, R. M. M., & Goudswaard, A. N. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_6 · Cited by 41
Nutrient supplements and cardiovascular disease: a heartbreaking story
Lichtenstein, A. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800027-jlr200 · Cited by 44
Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins
Asselbergs, F. W., van der Harst, P., Jessurun, G. A. J., Tio, R. A., & van Gilst, W. H. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.01.009 · Cited by 44
Vitamin B6 and Cardiovascular Disease
Friso, S., Lotto, V., Corrocher, R., & Choi, S. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2199-9_14 · Cited by 49
Min, P., Jung, J.-H., Ko, Y., Choi, D., Jang, Y., & Shim, W. (2007) · Circulation Journal · doi:10.1253/circj.71.1685 · Cited by 38
Shishehbor, M. H., Oliveira, L., Lauer, M. S., Sprecher, D. L., Wolski, K., Cho, L., Hoogwerf, B. J., & Hazen, S. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.060 · Cited by 38
Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario
Prabhakar, S. K., Majumdar, S., Khullar, M., Lal, V., Das, C., & Modi, M. (2005) · Neurology India · doi:10.4103/0028-3886.16927 · Cited by 44
Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion
Marcucci, R., Sodi, A., Giambene, B., Liotta, A. A., Poli, D., Mannini, L., Falciani, M., Abbate, R., Menchini, U., & Prisco, D. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32809cc922 · Cited by 40
Sun, L., Sun, S., Li, Y., Pan, W., Xie, Y., Wang, S., & Zhang, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132694 · Cited by 36
Spence, J. D. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0020-8 · Cited by 34
Association between serum folate and cardiovascular deaths among adults with hypertension
Nkemjika, S., Ifebi, E., Cowan, L., Fung, I. C., Twum, F., Liu, F., & Zhang, J. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0533-7 · Cited by 35
Olthof, M. R., Bots, M. L., Katan, M., & Verhoef, P. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010010 · Cited by 38
Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes
Imasa, M. S. B., Gomez, N. T., & Nevado, J. B. (2009) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492309102494 · Cited by 31
Araki, R., Maruyama, C., Igarashi, S., Yoshida, M., Maruyama, T., Satoh, T., Yoshida, M., & Umegaki, K. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602351 · Cited by 31
Li, S., Sun, L., Qi, L., Jia, Y., Cui, Z., Wang, Z., Li, F., & Zhao, X. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000829 · Cited by 31
Verdoia, M., Nardin, M., Gioscia, R., Afifeh, A. M. S., Viglione, F., Negro, F., Marcolongo, M., Luca, G. D., & the Novara Atherosclerosis Study Group (NAS) (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02391-w · Cited by 39
The importance of (early) folate status to primary and secondary coronary artery disease prevention
Muskiet, F. A. J. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.03.013 · Cited by 33
Varteresian, T. C., & Lavretsky, H. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0456-x · Cited by 33
de Bree, A., Mennen, L. I., Zureik, M., Ducros, V., Guilland, J.-C., Nicolas, J., Fillon-Emery, N., Blacher, J., Herçberg, S., & Galan, P. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.045 · Cited by 30
Zhang, Z., Foster, J. K., Kolm, P., Jurkovitz, C. T., Parker, K. M., Murrah, N. V., Anderson, G. T., Douglas, J. S., & Weintraub, W. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.03.018 · Cited by 28
Lonn, E. (2007) · Current Opinion in Internal Medicine · doi:10.1097/moh.0b013e3282c48bd8 · Cited by 28
Zittan, E., Preis, M., Asmir, I., Cassel, A., LINDENFELD, N., Alroy, S., Halon, D. A., Lewis, B. S., Shiran, A., Schliamser, J. E., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01189.2006 · Cited by 31
Risk Factors for Atherosclerotic Vascular Disease
von Eckardstein, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_2 · Cited by 33
Restenosis related to percutaneous coronary intervention has been solved?
Kivelä, A., & Hartikainen, J. E. K. (2006) · Annals of Medicine · doi:10.1080/07853890600643404 · Cited by 27
Total Plasma Homocysteine and Arteriosclerotic Outcomes in Type 2 Diabetes with Nephropathy
Friedman, A. N., Hunsicker, L. G., Selhub, J., & Bostom, A. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100846 · Cited by 26
Homocysteine: The Rubik's Cube of Cardiovascular Risk Factors
Milani, R. V., & Lavie, C. J. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.11.1200 · Cited by 29
Is plasma homocysteine a modifiable risk factor for stroke?
Hankey, G. J. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0093 · Cited by 31
Homocysteine: Call Off the Funeral
Spence, J. D. (2006) · Stroke · doi:10.1161/01.str.0000199621.28234.e2 · Cited by 29
Mager, A., Orvin, K., Koren‐Morag, N., Lev, I. E., Assali, A. R., Kornowski, R., Shohat, M., Battler, A., & Hasdai, D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.011 · Cited by 29
Wang, H., Liu, J., Wang, Q., Zhao, H., Shi, H., Yu, X., & Fu, X. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002483 · Cited by 23
Modified Cretan Mediterranean Diet in the Prevention of Coronary Heart Disease and Cancer: An Update
de Lorgeril, M., & Salen, P. (2006) · KARGER eBooks · doi:10.1159/000097870 · Cited by 28
Melhem, A., Desai, A. A., & Hofmann, M. A. (2009) · Thrombosis Journal · doi:10.1186/1477-9560-7-5 · Cited by 23
Anti-inflammatory strategies for homocysteine-related cardiovascular disease
Lin, C. P. (2009) · Frontiers in bioscience · doi:10.2741/3492 · Cited by 24
Homocysteine and Its Effects on In-Stent Restenosis
Luca, G. D., Suryapranata, H., Gregorio, G., Lange, H. W., & Chiariello, M. (2005) · Circulation · doi:10.1161/circulationaha.105.573923 · Cited by 25
Self-citationUpdating the Relationship between Hyperhomocysteinemia Lowering Therapy and Cardiovascular Events
Cheng, X. (2013) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12014 · Cited by 24
Han, J. H., Zhao, C., Cai, J., & Liang, Y. (2020) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101142 · Cited by 25
Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?
Maron, B. A., & Loscalzo, J. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0048-x · Cited by 23
Mandatory fortification of flour with folic acid: an overdue public health opportunity
MABERLY, G. F., & Stanley, F. J. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb07078.x · Cited by 27
Chang, T., Chou, K.-J., Tseng, C., Chung, H., Fang, H.-C., Hung, Y., Wu, M., Tzeng, H., Lind, C., & Lu, K. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x218077 · Cited by 22
Verdoia, M., Schaffer, A., Pergolini, P., Rolla, R., Barbieri, L., Bellomo, G., Sinigaglia, F., Marino, P. N., Suryapranata, H., & Luca, G. D. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000240 · Cited by 20
Self-citationKyte, B. B., Ifebi, E., Shrestha, S., Charles, S., Liu, F. M., & Zhang, J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.08.007 · Cited by 20
Potena, L., Grigioni, F., Magnani, G., Ortolani, P., Coccolo, F., Sassi, S., Koessels, K., Marrozzini, C., Marzocchi, A., Carigi, S., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01015.x · Cited by 19
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting
Girelli, D., Martinelli, N., Olivieri, O., Pizzolo, F., Friso, S., Faccini, G., Bozzini, C., Tenuti, I., Lotto, V., Villa, G., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000083 · Cited by 21
PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease
Ponce-Ruiz, N., Murillo-González, F. E., Rojas‐García, A. E., Barrón-Vivanco, B. S., Bernal-Hernández, Y. Y., González-Arias, C. A., Ortega-Cervantes, L., Ponce-Gallegos, J., López‐Guarnido, O., & Medina‐Díaz, I. M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111062 · Cited by 19
Carlsson, C. M., Pharo, L. M., Aeschlimann, S. E., Mitchell, C., Underbakke, G. L., & Stein, J. H. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.023 · Cited by 19
Lin, C., Chen, Y., Lin, W., Leu, H., Liu, T. Z., Huang, S., & Chen, J. W. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01911.x · Cited by 18
Iron-dependent formation of homocysteine from methionine and other thioethers
Baggott, J. E., & Tamura, T. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602665 · Cited by 20
Chen, Z., Qian, J., Chen, Y., Ma, J., & Ge, J. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.64 · Cited by 17
Serum folate levels and fatality among diabetic adults: A 15-y follow-up study of a national cohort
Afriyie-Gyawu, E., Ifebi, E., Ampofo‐Yeboah, A., Kyte, B. B., Shrestha, S., & Zhang, J. (2015) · Nutrition · doi:10.1016/j.nut.2015.10.021 · Cited by 18
Carlsson, C. M. (2006) · Drugs & Aging · doi:10.2165/00002512-200623060-00004 · Cited by 21
Woodward, M., Rumley, A. G., Rumley, A., Rumley, C. N., Lewington, S., Morrison, C. E., & Lowe, G. D. O. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000195919.71950.f7 · Cited by 18
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy
Barbieri, L., Verdoia, M., Schaffer, A., Niccoli, G., Filardi, P. P., Bellomo, G., Marino, P. N., Suryapranata, H., & Luca, G. D. (2014) · Angiology · doi:10.1177/0003319714533401 · Cited by 17
Self-citationLekakis, J. P., Papamichael, C. M., Papaioannou, T., Dagre, A. G., Stamatelopoulos, K., Tryfonopoulos, D. J., Protogerou, A. D., Stamatelopoulos, S., & Mavrikakis, M. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200410000-00010 · Cited by 20
Crowe, F. L., Skeaff, C. M., McMahon, J. A., Williams, S., & Green, T. (2008) · Journal of Nutrition · doi:10.1093/jn/138.3.551 · Cited by 17
Chia, S., Wilson, R., Ludlam, C. A., Webb, D. J., Flapan, A. D., & Newby, D. E. (2004) · Clinical Science · doi:10.1042/cs20040150 · Cited by 16
Folate in colorectal cancer, prostate cancer and cardiovascular disease
Guelpen, B. R. V. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601161513 · Cited by 17
Schaffer, A., Verdoia, M., Barbieri, L., Cassetti, E., Suryapranata, H., & Luca, G. D. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000441478 · Cited by 15
Self-citationWater-soluble Vitamins: Research Update
Bruno, E. J., & Ziegenfuss, T. N. (2005) · Current Sports Medicine Reports · doi:10.1097/01.csmr.0000306209.56939.48 · Cited by 14
Lupoli, R., Minno, A. D., Spadarella, G., Franchini, M., Sorrentino, R., Cirino, G., & Minno, G. D. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1549848 · Cited by 17
Elmore, C. L., & Matthews, R. G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1795 · Cited by 19
Elevated homocysteine and hypertension in Xinjiang Province, China.
Lu, H., Lu, Z. H., Li, P. G., Wang, Y. Y., & Yan, Z. (2010) · PubMed · Cited by 13
Twum, F., Morte, N., Wei, Y., Nkemjika, S., Liu, F., & Zhang, J. (2020) · Hypertension Research · doi:10.1038/s41440-020-0482-5 · Cited by 14
Homocysteine, Folate and Vitamin B12 in Patients with Coronary Heart Disease
Genser, D., Prachar, H., Hauer, R., Halbmayer, W., Mlczoch, J., & Elmadfa, I. (2006) · Annals of Nutrition and Metabolism · doi:10.1159/000094632 · Cited by 13
Qin, X., Fan, F., Cui, Y., Chen, F., Chen, Y., Cheng, X., Li, Y., Wang, B., Xu, X. P., Xu, X., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.01.006 · Cited by 13
Nevado, J. B., & Imasa, M. S. B. (2008) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282f52910 · Cited by 15
HOPE 2: can supplementation with folic acid and B vitamins reduce cardiovascular risk?
Kullo, I. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0611 · Cited by 12
Cardiovascular Disease: Strategies for Risk Assessment and Modification
Braun, L. T. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200611001-00004 · Cited by 15
Nutrients and cardiovascular disease: no easy answers – editorial review
Lichtenstein, A. H. (2005) · Current Opinion in Lipidology · doi:10.1097/00041433-200502000-00002 · Cited by 12
Economic issues in coronary heart disease prevention in India
Gupta, R., Prakash, H., & Gupta, R. R. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001871 · Cited by 11
Acquired Thrombophilia during Pregnancy
Dentali, F., & Crowther, M. A. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2006.05.006 · Cited by 11
Risk Markers for Atherothrombotic Disease
Ridker, P. M., & Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00044-5 · Cited by 16
Luca, G. D., Suryapranata, H., Hof, A. W. J. V. ’., Ottervanger, J. P., Hoorntje, J. C. A., Dambrink, J. E., Gosselink, A. T. M., & de Boer, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.023 · Cited by 10
Self-citationHomocysteine and Large Arteries
van Guldener, C., & Stehouwer, C. D. A. (2006) · KARGER eBooks · doi:10.1159/000096748 · Cited by 11
B vitamins and cognitive function: do we need more and larger trials?1,2
Vollset, S. E., & Ueland, P. M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.951 · Cited by 9
Folate: Is Too Much of a Good Thing Harmful?
Mullin, G. E. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533610392238 · Cited by 9
Testing the homocysteine hypothesis in end-stage renal disease: Problems and a possible solution
Hoffer, L. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000279 · Cited by 10
Folic Acid–Based Multivitamin Therapy to Prevent Stroke: The Jury Is Still Out
Hankey, G. J., & Eikelboom, J. W. (2004) · Stroke · doi:10.1161/01.str.0000135228.20619.ad · Cited by 10
Hoe ‘community-based’ werkt de huisarts?
de Bakker, D. H. (2006) · Huisarts en Wetenschap · doi:10.1007/bf03084773 · Cited by 10
Pietruszyńska-Reszetarska, A., Pietruszyński, R., & Irzmański, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136924 · Cited by 8
MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting
Verdoia, M., Schaffer, A., Cassetti, E., Barbieri, L., Giovine, G. D., Marino, P. N., & Luca, G. D. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.10.027 · Cited by 8
A magnetic nanoparticles-based method for DNA extraction from the saliva of stroke patients.
Li, Y., Huang, Y., Wu, T., & Wu, J. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.32.007 · Cited by 14
Folic acid supplementation reduces plasma homocysteine in postmenopausal women
Almassinokiani, F., Kashanian, M., Akbari, P., Mossayebi, E., & Sadeghian, E. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2015.1091811 · Cited by 9
González, J. M., Millán, E. R., Julve, J., & Blanco‐Vaca, F. (2010) · Revista de Neurología · doi:10.33588/rn.5004.2009081 · Cited by 11
New insights in preventive cardiology and cardiac rehabilitation
Franklin, B. A., Trivax, J. E., & Vanhecke, T. E. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32830b360b · Cited by 8
Homocystein als kardiovaskulärer Marker und Risikofaktor
Pietrzik, K. F. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-1806-4 · Cited by 8
Prevention of Cardiovascular Events after Percutaneous Coronary Intervention
Herrmann, H. C. (2004) · New England Journal of Medicine · doi:10.1056/nejme048096 · Cited by 8
Metadata
- Authors
- Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E.
- Affiliations
- Klinikum Links der Weser (DE)
- Isala (NL)
- Diagram (Netherlands) (NL)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-24
- Volume
- 350
- Issue
- 26
- Pages
- 2673-2681
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1968517325
- Cited by
- 336
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 13 · 2013: 14 · 2012: 12
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- folate therapy, in-stent restenosis, coronary stenting, vitamin B6, vitamin B12, folic acid, homocysteine, late lumen loss, target vessel revascularization, coronary angioplasty, vitamin supplementation
- MeSH terms
- Aged, Coronary Disease, Coronary Vessels, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Homocysteine, Humans, Male, Middle Aged, Risk Factors, Vitamin B 12, Stents, Coronary Angiography, Treatment Failure, Hyperhomocysteinemia, Coronary Restenosis, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.